MLH1 promoter methylation, diet, and lifestyle factors in mismatch repair deficient colorectal cancer patients from EPIC-Norfolk

Nutrition and Cancer

Volumn 63, Issue 7, 2011, Pages 1000-1010

  Gay, Laura J ^a   Arends, Mark J ^b   Mitrou, Panagiota N ^b   Bowman, Richard ^a   Ibrahim, Ashraf E ^b   Happerfield, Lisa ^b   Luben, Robert ^b   McTaggart, Alison ^b   Ball, Richard Y ^c   Rodwell, Sheila A ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; MISMATCH REPAIR PROTEIN; PROTEIN MLH1;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; COLORECTAL CANCER; CONTROLLED STUDY; DIET; FEMALE; FRUIT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PHYSICAL ACTIVITY; PROTEIN DEFICIENCY; QUESTIONNAIRE; TUMOR DIFFERENTIATION; VEGETABLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; COLORECTAL NEOPLASMS; DIET; DNA; DNA METHYLATION; DNA MISMATCH REPAIR; FEMALE; FRUIT; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; LIFE STYLE; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; QUESTIONNAIRES; SMOKING; VEGETABLES;

EID: 80053636272     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.596987     Document Type: Article

References (46)

1. Narayan S and Roy D: Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer 2, 41-55, 2003.
2. Peltomaki P: Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10, 735-740, 2001. (Pubitemid 32331582)
3. Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, et al.: Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48, 821-829, 2001. (Pubitemid 32476985)
4. Arends MJ and Frayling I: Mismatch repair deficiency in hereditary and sporadic colorectal cancer (UK key advances in clinical practice). In: The Effective Management of Colorectal Cancer, Cunningham D, Topham C, and Miles A (eds.). London: Aesculapius Medical Press, 2005, pp. 25-40.
5. Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, and Pel-tomaki P: Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 156, 1773-1779, 2000. (Pubitemid 30646714)
6. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, et al.: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorec-tal carcinoma. Proc Natl Acad Sci USA 95, 6870-6875, 1998. (Pubitemid 28278073)
7. Chai SM, Zeps N, Shearwood AM, Grieu F, Charles A, et al.: Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients. Clin Gastroenterol Hepatol 2, 1017-1025, 2004. (Pubitemid 39539752)
8. Salahshor S, Kressner U, Pahlman L, Glimelius B, Lindmark G, et al.: Col-orectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer 26, 247-252, 1999. (Pubitemid 29468345)
9. Diergaarde B, Braam H, van Muijen GN, Ligtenberg MJ, Kok FJ, et al.: Dietary factors and microsatellite instability in sporadic colon carcinomas. Cancer Epidemiol Biomarkers Prev 12, 1130-1136, 2003. (Pubitemid 37499434)
10. Mas S, Lafuente MJ, Crescenti A, Trias M, Ballesta A, et al.: Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1. Anticancer Res 27, 1151-1156, 2007. (Pubitemid 46587034)
11. Satia JA, Keku T, Galanko JA, Martin C, Doctolero RT, et al.: Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 14, 429-436, 2005. (Pubitemid 40270108)
12. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, et al.: Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92, 1831-1836, 2000.
13. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruine AP, et al.: Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 63, 3133-3137, 2003. (Pubitemid 36735864)
14. Wark PA, Weijenberg MP, van 't Veer P, van Wijhe G, Luchtenborg M, et al.: Fruits, vegetables, and hMLH1 protein-deficient and-proficient colon cancer: the Netherlands cohort study. Cancer Epidemiol Biomarkers Prev 14, 1619-1625, 2005. (Pubitemid 40995070)
15. Wu AH, Shibata D, Yu MC, Lai MY, and Ross RK: Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas. Carcino-genesis 22, 1681-1684, 2001. (Pubitemid 32952147)
16. Yang P, Cunningham JM, Halling KC, Lesnick TG, Burgart LJ, et al.: Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab 71, 639-645, 2000. (Pubitemid 32039350)
17. Kim YI: Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13, 511-519, 2004.
18. Homann N, Tillonen J, and Salaspuro M: Microbially produced acetalde-hyde from ethanol may increase the risk of colon cancer via folate deficiency. Int J Cancer 86, 169-173, 2000. (Pubitemid 30180810)
19. Diergaarde B, Vrieling A, van Kraats AA, van Muijen GN, Kok FJ, et al.: Cigarette smoking and genetic alterations in sporadic colon carcinomas. Carcinogenesis 24, 565-571, 2003. (Pubitemid 36432654)
20. Luchtenborg M, Weijenberg MP, de Goeij AF, Wark PA, Brink M, et al.: Meat and fish consumption, APC gene mutations and hMLH1 expression in colon and rectal cancer: a prospective cohort study (the Netherlands). Cancer Causes Control 16, 1041-1054, 2005. (Pubitemid 41356001)
21. Schernhammer ES, Giovannucci E, Fuchs CS, and Ogino S: A prospective study of dietary folate and vitamin b and colon cancer according to microsatellite instability and KRAS mutational status. Cancer Epidemiol Biomarkers Prev 17, 2895-2898, 2008.
22. Bingham SA, Cassidy A, Cole TJ, Welch A, Runswick SA, et al.: Validation of weighed records and other methods of dietary assessment using the 24 h urine nitrogen technique and other biological markers. Br J Nutr 73, 531-550, 1995.
23. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, et al.: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5, 1113-1124, 2002. (Pubitemid 36313608)
24. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al.: A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58, 5248-5257, 1998. (Pubitemid 28521189)
25. Mikeska T, Bock C, El-Maarri O, Hubner A, Ehrentraut D, et al.: Optimization of quantitative MGMT promoter methylation analysis using py-rosequencing and combined bisulfite restriction analysis. J Mol Diagn 9, 368-381, 2007. (Pubitemid 47305073)
26. Day N, Oakes S, Luben R, Khaw KT, Bingham S, et al.: EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80(S1), 95-103, 1999. (Pubitemid 29389613)
27. Park JY, Mitrou PN, Keen J, Dahm CC, Gay LJ, et al.: Lifestyle factors and p53 mutation patterns in colorectal cancer patients in the EPIC-Norfolk study. Mutagenesis 25, 351-358, 2010.
28. Frayling IM, Happerfield L, Mattocks C, Oakhill K, and Arends MJ: Application of Molecular diagnostics to hereditary nonpolyposis colorectal cancer. In: Molecular Diagnostics for the Clinical Laboratorian, Cole-man WD and Tsongalis GJ (eds.). Totowa, NJ: Humana Press, Inc., 2003, pp. 375-392.
29. Wu K, Bowman R, Welch AA, Luben RN, Wareham N, et al.: Apolipopro-tein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. Eur Heart J 28, 2930-2936, 2007. (Pubitemid 350233040)
30. Arends MJ, Ibrahim M, Happerfield L, Frayling I, and Miller K: Interpretation of immunohistochemical analysis of mismatch repair (MMR) protein expression in tissue sections for investigation of suspected Lynch/Hereditary Non-Polyposis Colorectal Cancer (HN-PCC) syndrome. UK NEQAS ICC ISH Recommendations 1, 1-2, 2008.
31. Sargeant LA, Khaw KT, Bingham S, Day NE, Luben RN, et al.: Cigarette smoking and glycemia: the EPIC-Norfolk Study European Prospective Investigation into Cancer. Int J Epidemiol 30, 547-554, 2001. (Pubitemid 32600248)
32. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, et al.: Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6, 407-413, 2003. (Pubitemid 36749764)
33. Bingham SA, Welch AA, McTaggart A, Mulligan AA, Runswick SA, et al.: Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr 4, 847-858, 2001. (Pubitemid 32566539)
34. Welch AA, McTaggart A, Mulligan AA, Luben R, Walker N, et al.: DINER (Data Into Nutrients for Epidemiological Research): a new data-entry program for nutritional analysis in the EPIC-Norfolk cohort and the 7-day diary method. Public Health Nutr 4, 1253-1265, 2001. (Pubitemid 34027214)
35. de Vogel S, Bongaerts BW, Wouters KA, Kester AD, Schouten LJ, et al.: Associations of dietary methyl donor intake with MLH1 promoter hyper-methylation and related molecular phenotypes in sporadic colorectal cancer. Carcinogenesis 29, 1765-1773, 2008.
36. Luchtenborg M, Weijenberg MP, Kampman E, van Muijen GN, Roemen GM, et al.: Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. Am J Epidemiol 161, 806-815, 2005. (Pubitemid 40577834)
37. Slattery ML, Anderson K, Curtin K, Ma KN, Schaffer D, et al.: Dietary intake and microsatellite instability in colon tumors. Int J Cancer 93, 601-607, 2001. (Pubitemid 32701421)
38. Samowitz WS, Slattery ML, Potter JD, and Leppert MF: BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. Am J Pathol 154, 1637-1641, 1999. (Pubitemid 29262844)
39. Yu J, Freimuth RR, Culverhouse R, Marsh S, Watson MA, et al.: DNA methlotype analysis in colorectal cancer. Oncol Rep 20, 921-927, 2008
40. Buttin BM, Powell MA, Mutch DG, Rader JS, Herzog TJ, et al.: Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. Clin Cancer Res 10, 481-490, 2004. (Pubitemid 38173986)
41. Bingham SA, Luben R, Welch A, Wareham N, Khaw KT, et al.: Are imprecise methods obscuring a relation between fat and breast cancer? Lancet 362, 212-214, 2003. (Pubitemid 36859940)
42. McKeown NM, Day NE, Welch AA, Runswick SA, Luben RN, et al.: Use of biological markers to validate self-reported dietary intake in a random sample of the European Prospective Investigation into Cancer United Kingdom Norfolk cohort. Am J Clin Nutr 74, 18-96, 2001.
43. Larsson SC and Wolk A: Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer 119, 2657-2664, 2006. (Pubitemid 44691322)
44. Povey AC, Hall CN, Badawi AF, Cooper DP, and O'Connor PJ: Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel. Gut 47, 362-365, 2000.
45. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, et al.: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96, 8681-8686, 1999. (Pubitemid 29354851)
46. Slattery ML, Edwards SL, Palmer L, Curtin K, Morse J, et al.: Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. Mutat Res 432, 7-14, 2000. (Pubitemid 30151204)